Previous 10 | Next 10 |
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results PR Newswire SAN DIEGO , Aug. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp e...
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023 PR Newswire SAN DIEGO , Aug. 1, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company sp...
CV Sciences to Participate in LD Micro Invitational Conference PR Newswire 13th invitational event welcomes over 150 companies to over 800 attendees SAN DIEGO , June 1, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Scienc...
2023-05-15 12:09:10 ET CV Sciences, Inc. (CVSI) Q1 2023 Earnings Conference Call May 15, 2023, 10:00 AM ET Company Participants Joseph Dowling - CEO, Secretary and Director Joerg Grasser - CFO Conference Call Participants Presentation Operator ...
2023-05-15 09:07:45 ET CV Sciences press release ( OTCQB:CVSI ): Q1 Non-GAAP EPS of $0.00. Revenue of $4.15M (-6.7% Y/Y). For further details see: CV Sciences Non-GAAP EPS of $0.00, revenue of $4.15M
CV Sciences, Inc. Reports First Quarter 2023 Financial Results PR Newswire SAN DIEGO , May 15, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ex...
CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023 PR Newswire SAN DIEGO , May 9, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company special...
CV Sciences, Inc. Introduces New THC Offering PR Newswire +PlusCBD™ Reserve Collection Extra Gummies provide easy-to-dose 5mg THC option SAN DIEGO , April 3, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Scien...
2023-03-29 13:32:06 ET CV Sciences, Inc. (CVSI) Q4 2022 Earnings Call Transcript March 29, 2023 10:00 AM Company Participants Joseph Dowling - CEO, Secretary and Director Joerg Grasser - CFO Conference Call Participants Presentation Operator ...
2023-03-29 09:06:20 ET CV Sciences press release ( OTCQB:CVSI ): FY Non-GAAP EPS of -$0.05. Revenue of $16.2M (-19.2% Y/Y). Cash balance of $0.6 million at year end compared to $1.4 million at the end of 2021; Recognized gross margin of 34.2% for fiscal year 2022 compa...
News, Short Squeeze, Breakout and More Instantly...
CV Sciences, Inc. Reports First Quarter 2024 Financial Results PR Newswire SAN DIEGO , May 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ex...
CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER PR Newswire SAN DIEGO , May 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer we...
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024 PR Newswire SAN DIEGO , May 8, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company special...